Read more

May 03, 2022
4 min watch
Save

VIDEO: More retinal tissue preserved over time with pegcetacoplan

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

DENVER — Pegcetacoplan was effective at preserving retinal tissue in patients with geographic atrophy, with an increasing magnitude of effect over time, according to Roger Goldberg, MD, here at the ARVO meeting.

When combining results from the DERBY and OAKS phase 3 trials at 18 months, the dose response curve showed that monthly injections were more effective than every other month, he said.

Editor's note: On May 12, 2022, this headline and caption were updated to better reflect the key takeaway from the study.